Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]

Prognostic significance of progesterone receptor-positive tumour cells within...

Dr Aleix Prat - University of North Carolina, USA

Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer ( Dr Aleix Prat - University of North Carolina, USA )

Innovation in molecular imaging

Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA

Innovation in molecular imaging ( Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA )

Personalised medicine and nursing

Paula Reiger – Oncology Nursing Society, USA

Personalised medicine and nursing ( Paula Reiger – Oncology Nursing Society, USA )

Oncology nurses should take the lead

Birgitte Grube - President of EONS

Oncology nurses should take the lead ( Birgitte Grube - President of EONS )

Communication in genetics and genomics

Anne-Elizabeth Murphy - Hôpitaux Universitaires de Genève, Switzerland

Communication in genetics and genomics ( Anne-Elizabeth Murphy - Hôpitaux Universitaires de Genève, Switzerland )

Targeted therapy for refractory Ewing’s Sarcoma tumours

Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA

$Targeted therapy for refractory Ewing’s Sarcoma tumours ( Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA )$

Mouse models of metastatic breast cancer

Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam

Mouse models of metastatic breast cancer ( Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam )

Analysis of thirty years of clinical trial data

Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK

Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )

Recent advances in multiple myeloma therapy

Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios...

Recent advances in multiple myeloma therapy ( Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon )

Recent advances in non-Hodgkin’s lymphoma therapy

Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter

Recent advances in non-Hodgkin’s lymphoma therapy ( Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter )

BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory...

Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston

$BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma ( Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston )$

Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell...

Dr Laurie Sehn - University of British Columbia, Vancouver, Canada

Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )

More from ecancer